Ultra-Fast Middle-Up Reversed Phase Liquid Chromatography Analysis of Complex Bispecific Antibodies Obtained in Less Than One Minute.

bispecific antibodies improved selectivity method robustness reversed-phase liquid chromatography ultra-short columns

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
28 Oct 2022
Historique:
received: 28 09 2022
revised: 24 10 2022
accepted: 25 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

This work illustrates the benefits and limitations of using ultra-short reversed phase liquid chromatography (RPLC) columns for the characterization of various complex bispecific antibodies after prolonged thermal stress at the middle-up level of analysis. First, we have demonstrated that alternative organic modifiers, such as isopropanol, can be used in RPLC mode without generating excessive pressure, thanks to the prototype 10 × 2.1 mm, 2.7 µm particle column. However, compared to acetonitrile, the selectivity was not improved, at least for the selected biopharmaceutical products. Importantly, very fast separations (sub-1 min) of high quality were systematically obtained for the different samples when using a spectroscopic detector, but a severe loss of performance was observed with mass spectrometry (MS) detection due to dispersion effects. Based on these results, there is a clear need to improve the interfacing between LC and MS (shorter/thinner tubing) to mitigate band broadening.

Identifiants

pubmed: 36365134
pii: pharmaceutics14112315
doi: 10.3390/pharmaceutics14112315
pmc: PMC9698801
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Anal Chem. 2021 Jan 26;93(3):1277-1284
pubmed: 33332095
J Pharm Biomed Anal. 2014 Jan;87:105-19
pubmed: 23571029
Anal Chem. 2021 Jan 26;93(3):1285-1293
pubmed: 33305942
Anal Chem. 2022 Jun 7;94(22):7877-7884
pubmed: 35607711
Anal Chem. 1997 Jul 1;69(13):2530-6
pubmed: 9212712
J Chromatogr A. 2012 Mar 9;1228:57-71
pubmed: 21982449
Anal Chem. 2021 Aug 3;93(30):10644-10652
pubmed: 34279080
MAbs. 2017 Feb/Mar;9(2):182-212
pubmed: 28071970
Nat Rev Drug Discov. 2019 Aug;18(8):585-608
pubmed: 31175342
Nat Rev Drug Discov. 2021 Jul;20(7):491-495
pubmed: 33953368
J Chromatogr A. 2021 Apr 12;1642:462050
pubmed: 33735644
J Chromatogr A. 2013 Oct 4;1310:45-55
pubmed: 23993747

Auteurs

Amarande Murisier (A)

School of Pharmaceutical Sciences, University of Geneva, CMU-Rue Michel Servet 1, 1211 Geneva, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU-Rue Michel Servet 1, 1211 Geneva, Switzerland.

Valentina D'Atri (V)

School of Pharmaceutical Sciences, University of Geneva, CMU-Rue Michel Servet 1, 1211 Geneva, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU-Rue Michel Servet 1, 1211 Geneva, Switzerland.

Sebastian Pirner (S)

Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany.

Vincent Larraillet (V)

Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany.

Szabolcs Fekete (S)

Waters Corporation, CMU-Rue Michel Servet 1, 1211 Geneva, Switzerland.

Matthew Lauber (M)

Waters Corporation, 34 Maple Street, Milford, MA 01757-3696, USA.

Davy Guillarme (D)

School of Pharmaceutical Sciences, University of Geneva, CMU-Rue Michel Servet 1, 1211 Geneva, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU-Rue Michel Servet 1, 1211 Geneva, Switzerland.

Classifications MeSH